Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.9600
-0.0128 (-1.32%)
Aug 7, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Market Cap
Kairos Pharma has a market cap or net worth of $16.18 million as of August 7, 2025.
Market Cap
16.18M
Enterprise Value
12.56M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $16.18M, a decrease of -51.55%. That is a compound annual growth rate of -55.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 16.39M | -16.06% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| UnitedHealth Group | 221.95B |
| Novartis AG | 221.76B |
| Novo Nordisk | 213.92B |